悪性腫瘍の治療のためのシクロオキシゲナーゼ-2選択的阻害剤及びカルボニックアンヒドラーゼ阻害剤の組成物

Japanese Patent JP2005539022

A

Methods of treating or preventing carbonic anhydrase associated disorders or diseases in a subject in need of such treatment as prevention comprising the administration of cyclooxygenase-2 inhibitors, or structurally related compounds, having carbonic anhydrase inhibitory properties, as well as combinations of the cyclooxygenase-2 inhibitors, or structurally related compounds, with anti-inflammatory agents or drugs, antineoplastic agents or drugs or ophthalmic agents or drugs in methods of treatment and prevention of disorders or diseases.

Masefeller, James Elle
O'Neill, Janet M

JP2004527530A

December 22, 2005

February 14, 2003

Click for automatic bibliography generation  

Pharmacia Corporation

A61K31/10; A61K31/138; A61K31/18; A61K31/235; A61K31/27; A61K31/382; A61K31/407; A61K31/415; A61K31/4155; A61K31/4162; A61K31/4178; A61K31/4188; A61K31/4196; C07D231/12; A61K31/42; A61K31/421; A61K31/423; A61K31/428; A61K31/433; A61K31/4439; A61K31/4704; A61K31/4745; A61K31/4965; A61K31/501; A61K31/519; A61K31/5377; A61K31/541; A61K31/542; A61K31/549; A61K31/5575; A61K31/5578; A61K31/635; A61K31/661; A61K33/14; A61K45/00; A61K45/06; A61P1/02; A61P1/04; A61P3/10; A61P3/12; A61P5/14; A61P7/02; A61P7/06; A61P7/10; A61P9/00; A61P9/04; A61P9/10; A61P11/00; A61P11/06; A61P13/12; A61P15/08; A61P17/00; A61P17/02; A61P17/04; A61P19/02; A61P19/06; A61P21/00; A61P21/04; A61P25/02; A61P25/06; A61P25/08; A61P25/28; A61P27/02; A61P27/06; A61P27/12; A61P29/00; A61P35/00; A61P35/02; A61P37/06; A61P43/00; C07D231/14; C07D231/54; C07D231/56; C07D261/08; C07D263/32; C07D401/04; C07D405/04; C07D471/04; C07D487/04; C07D495/04; (IPC1-7): A61K45/06; A61K31/10; A61K31/4196; A61K31/421; A61K31/428; A61K31/433; A61K31/501; A61K31/541; A61K31/542; A61K31/549; A61P35/00; A61P43/00

Kazuo Shamoto
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Hiroko Ejiri

Previous Patent: ２−（３−アミノアリール）アミノ−４−アリール−チアゾールおよびそ�...

Next Patent: 炭酸脱水酵素媒介疾患の治療方法